Penicillamine Tablets USP 250 mg, 100-count bottle, Rx Only, Manufactured for: Lupin Pharmaceutic...

FDA Recall #D-0148-2024 — Class II — November 22, 2023

Recall #D-0148-2024 Date: November 22, 2023 Classification: Class II Status: Terminated

Product Description

Penicillamine Tablets USP 250 mg, 100-count bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202 Manufactured by: Lupin Limited, Nagpur-441 108, India, NDC# 70748-153-01

Reason for Recall

Failed Dissolution Specifications

Recalling Firm

Lupin Pharmaceuticals Inc. — Baltimore, MD

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

N/A

Distribution

Product was distributed to 3 wholesale/distributor accounts.

Code Information

Lot # M200498, Exp. June 2024

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated